ERBB2 and cancer: Despite the ability of bi-TPB-PPB antibodies to bind HER2 oncoprotein on the surface of cancer cells, Fig. 3 shows that the proliferation inhibition assay did not reveal any inhibition of BT-474 cell proliferation in the presence of both types of bi-TPB-PPB antibodies.